Carlyle Group L.P. is a Public Company based in Washington, DC led by Harvey M. Schwartz, managing $4.3B across 16 long positions as of Q3 2025 with 97% Unknown concentration, 100% concentrated in top 10 holdings, and 97% allocation to SARO.
Largest long holdings in Carlyle Group L.P.'s portfolio (99.8% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Unknown Unknown | $4.2B | 97.24% | — | 45.65% 152.7M shares | |
Biotechnology Healthcare | $41.1M | 0.96% | — | 4.93% 3.5M shares | |
Biotechnology Healthcare | $24.8M | 0.58% | +$24.8M Bought | 100.00% 2.9M shares | |
REIT - Residential Real Estate | $14.0M | 0.33% | — | 0.08% 477.5K shares | |
Internet Content & Information Communication Services | $12.3M | 0.29% | — | 1.50% 6.2M shares | |
REIT - Industrial Real Estate | $9.0M | 0.21% | — | 0.10% 220.5K shares | |
Integrated Freight & Logistics Industrials | $3.1M | 0.07% | — | 0.35% 107.2K shares | |
Biotechnology Healthcare | $2.5M | 0.06% | — | 3.82% 1.1M shares | |
Biotechnology Healthcare | $2.4M | 0.06% | — | 3.54% 2.9M shares | |
Solar Energy | $2.2M | 0.05% | -$578.2K Sold | 1.46% 1.3M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Carlyle Group L.P.'s latest filing
| Position | Shares Δ |
|---|---|
| No increased positions | |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
-20.69% |
Portfolio insights and performance metrics for Carlyle Group L.P.
We use cookies for analytics. See our Privacy and Cookie Policy.